Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial Academic Article uri icon

Overview

MeSH Major

  • General Surgery
  • Neoplasms

abstract

  • US National Institutes of Health and Novartis Pharmaceuticals.

publication date

  • March 27, 2009

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(09)60500-6

Additional Document Info

start page

  • 1097

end page

  • 104

volume

  • 373

number

  • 9669